Allergen-Specific Immunotherapy (AIT) for Allergic Diseases of the Respiratory Tract and Food Allergies
A special issue of Journal of Clinical Medicine (ISSN 2077-0383). This special issue belongs to the section "Immunology".
Deadline for manuscript submissions: 30 June 2025 | Viewed by 555
Special Issue Editor
Interests: allergic disease; infectious diseases; upper respiratory tract
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Allergen-specific immunotherapy (AIT) is the only disease-modifying treatment for respiratory allergies such as allergic rhinoconjunctivitis and allergic asthma. In view of the still increasing prevalence of these diseases in many regions of the world, it is therefore of fundamental health and economic importance.
Over the last decade, clinical research in the field of allergen-specific immunotherapy has focused on intensive research efforts to create evidence for sublingual tablets and liquids that contain high-dose native allergens for allergic rhinoconjunctivitis but also, for the first time, for allergic asthma, which no longer represents a contraindication for AIT. At the same time, however, there is no end to the number of studies that could examine new therapeutic approaches for clinical implementation. Suitable topics of interest for this Special Issue include, but are not limited to, the following: recombinant allergens, peptides targeting B or T cells, as well as novel adjuvants coupled with chemically modified allergens, so-called allergoids. Numerous clinical trials are nearing completion or have already been analyzed and could be presented here. This Special Issue also aims to shed light on the use of innovative diagnostic methods in AIT phase two and three trials. Food allergy is now also a target of AIT and should be highlighted as well.
Prof. Dr. Ralph Mösges
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- allergy
- allergic rhinitis
- allergic conjunctivitis
- allergic asthma
- food allergy
- peptide immunotherapy
- allergoids
- SLIT
- SCIT
- OIT
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue policies can be found here.
